about
COPD immunopathologyTargeted anti-inflammatory therapeutics in asthma and chronic obstructive lung diseasePositioning new pharmacotherapies for COPDSirtuin 1 and aging theory for chronic obstructive pulmonary diseaseChemical constituents of tobacco smoke induce the production of interleukin-8 in human bronchial epithelium, 16HBE cellsIs periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cellsImbalance of dendritic cell co-stimulation in COPD.Chrysin suppresses cigarette smoke-induced airway inflammation in mice.Interleukin-17A and Toll-Like Receptor 3 Ligand Poly(I:C) Synergistically Induced Neutrophil Chemoattractant Production by Bronchial Epithelial Cells.Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter.Berberine attenuates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice.Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.Probing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling.Distinctive Regulatory T Cells and Altered Cytokine Profile Locally in the Airways of Young Smokers with Normal Lung Function.Effects of Chung-Pae Inhalation Therapy on a Mouse Model of Chronic Obstructive Pulmonary Disease.Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.Total Synthesis of the Potent Marine-Derived Elastase Inhibitor Lyngbyastatin 7 and in Vitro Biological Evaluation in Model Systems for Pulmonary DiseasesIn situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.Carbocisteine attenuates TNF-α-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-κB and ERK1/2 MAPK signaling pathways.Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editingEmerging pharmaceutical therapies for COPD.SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3Recombinant CC16 protein inhibits the production of pro-inflammatory cytokines via NF-κB and p38 MAPK pathways in LPS-activated RAW264.7 macrophages.Up-Regulation of Claudin-6 in the Distal Lung Impacts Secondhand Smoke-Induced InflammationIncreased expression of Siglec-9 in chronic obstructive pulmonary disease.DJ-1 Modulates Nuclear Erythroid 2-Related Factor-2-Mediated Protection in Human Primary Alveolar Type II Cells in Smokers.A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease.Cxcl8b and Cxcr2 Regulate Neutrophil Migration through Bloodstream in ZebrafishThe Significance of Hypothiocyanite Production via the Pendrin/DUOX/Peroxidase Pathway in the Pathogenesis of Asthma.The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages.IL-17A and GDF15 are able to induce epithelial-mesenchymal transition of lung epithelial cells in response to cigarette smoke.Long-Term Outcomes in Patients with Incident Chronic Obstructive Pulmonary Disease after Acute Kidney Injury: A Competing-Risk Analysis of a Nationwide CohortIncreased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD
P2860
Q26749575-BACDF88A-7473-4B08-AC83-3AD8425DED93Q26786229-B4BB731D-1F14-4FBA-B93D-8E5D19ADF1DCQ26798659-33906474-24AC-4ECF-A804-57468EA41783Q26799889-B8AB9701-91E7-4764-B46A-65C1EE970ACEQ28829675-DE8CAD45-C2F2-40FC-BDA6-A34B956B9DC0Q33649907-068381BC-1CA8-483B-B3FE-95F686C5EEE6Q34227089-DAB3F3D5-BF27-4260-8ABB-0CBD088F3F08Q35105292-16F89B48-87B2-45F9-8576-2E3368B31C3DQ35479734-3A75D1A7-3CDF-4C9B-962C-59A9E8E785FFQ35822647-31594B21-56B3-4A3E-98AF-03BCF3F4E2FBQ35860853-18188C73-195E-4F1A-A33D-C17A29549645Q35959271-4D87FDAA-FBFB-44F7-BE07-1C523AE3E0DCQ36027413-9BCC1831-7FEA-4E70-A1D0-F18596381B61Q36145085-C53B1BA8-1F7F-48B3-AE5D-EE7F444B8115Q36178595-2AB41EE1-B701-403A-8C00-EC6B4A456F7FQ36204389-EE9F412B-9329-404C-9D1E-757336651C4FQ36243216-F9E1CC37-4654-4D73-94CE-2CD4F208C4DDQ36525035-3B0C1E04-8458-46EA-9D21-0C977BDC2B4FQ36649674-4BB3665D-03DE-424D-93B9-817C0550D35EQ36872129-03DE3AA5-4122-4391-A9BB-E3752796600FQ36907742-65DE3892-87E2-46AA-B308-A09095CD637AQ37157449-56F750CF-3AC2-4F45-A534-379C3DACCCF4Q38645203-F1687EB9-20F7-4505-A7F2-B7C6EB830CADQ38874085-CC977B64-EE73-4AC9-A0A3-40B06F97CDE7Q38879480-0531E4C6-F5D8-4422-8F57-0A6077990A98Q39267369-DBA06972-3297-414D-8D91-B7B282516C3DQ40071781-C99BB476-2864-4BA9-AB95-8CACCC2796E3Q40792236-198D4F62-C3FB-4AFD-86F5-074C2994B392Q41336850-C7522CD4-441C-4CA3-A6C4-BB594D592F78Q42176786-94791CB1-8BF6-4E79-BF98-E9FC0C078D16Q48189457-68C161A1-0225-42F1-A29A-4BEC9F5DBB60Q51740589-4765626B-BB47-45A3-8E82-63FEFB1EA5D5Q55518738-C4ADA085-6B49-41F1-9FF4-61DC0765CC87Q58704276-6BDE8947-6ABD-4E6D-BBE1-A6B13989B0ADQ58735852-DD73453D-385E-4340-A86A-93B4C3A82CAD
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cytokine inhibition in the treatment of COPD.
@ast
Cytokine inhibition in the treatment of COPD.
@en
Cytokine inhibition in the treatment of COPD.
@nl
type
label
Cytokine inhibition in the treatment of COPD.
@ast
Cytokine inhibition in the treatment of COPD.
@en
Cytokine inhibition in the treatment of COPD.
@nl
prefLabel
Cytokine inhibition in the treatment of COPD.
@ast
Cytokine inhibition in the treatment of COPD.
@en
Cytokine inhibition in the treatment of COPD.
@nl
P2860
P50
P921
P356
P1476
Cytokine inhibition in the treatment of COPD.
@en
P2093
Gaetano Caramori
P2860
P304
P356
10.2147/COPD.S42544
P407
P577
2014-04-28T00:00:00Z